Phase 1 dose escalation of SYS6002 (CRB-701), a next-generation nectin-4 targeting antibody drug conjugate (ADC).
| Autor: | Ye, Ding-Wei, Zhang, Jian, Yang, Hua, Yang, Jin, Zheng, Tongsen, Sun, Hongmei, Wan, Xuechao, Lan, Ge, Sun, Guilan, Zhang, Xiao |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p622-622, 193p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|